Insider Trading activities of Ionis Pharmaceuticals Inc insiders. , Part 5

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ionis Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ionis Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Ionis Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is IONS. The reporting company's CIK number is 874015.
The total value of stock buying since 2005 is $90,940.
The total value of stock sales since 2005 is $150,519,131.
The total value of stock option exercises since 2005 is $48,346,011.



Table 2. Detailed insider stock purchases, sales, and option exercises of Ionis Pharmaceuticals Inc insiders (IONS) , Part 5
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-02-15 O'neil Patrick R. (SVP, Legal & General Counsel) Sale 350 14.81 5,183
2013-02-15 O'neil Patrick R. (SVP, Legal & General Counsel) Option Ex 350 10.29 3,601
2013-02-13 O'neil Patrick R. (SVP, Legal & General Counsel) Sale 6,239 14.17 88,406
2013-02-13 O'neil Patrick R. (SVP, Legal & General Counsel) Option Ex 6,100 7.62 46,512
2013-01-30 O'neil Patrick R. (SVP, Legal and General Counsel) Sale 2,000 14.82 29,640
2013-01-30 O'neil Patrick R. (SVP, Legal and General Counsel) Option Ex 2,000 10.29 20,580
2013-01-29 O'neil Patrick R. (SVP, Legal and General Counsel) Sale 300 13.40 4,020
2013-01-17 O'neil Patrick R. (SVP, Legal & General Counsel) Sale 242 14.16 3,426
2013-01-16 Monia Brett P (SVP, Antisense Drug Discovery) Sale 330 14.00 4,620
2013-01-16 Geary Richard S (SVP, Development) Sale 345 14.00 4,830
2013-01-16 Hougen Elizabeth L (SVP, Finance & CFO) Sale 242 14.00 3,388
2013-01-16 Bennett C Frank (SVP, Antisense Research) Sale 309 14.00 4,326
2013-01-16 Parshall B Lynne (COO, Secretary) Sale 759 14.00 10,626
2013-01-16 Crooke Stanley T (Chairman, CEO and President) Sale 1,460 14.00 20,440
2013-01-15 O'neil Patrick R. (SVP, Legal & General Counsel) Option Ex 542 .00 0
2013-01-15 Monia Brett P (SVP, Antisense Drug Discovery) Option Ex 737 .00 0
2013-01-15 Geary Richard S (SVP, Development) Option Ex 776 .00 0
2013-01-15 Hougen Elizabeth L (SVP, Finance & CFO) Option Ex 542 .00 0
2013-01-15 Bennett C Frank (SVP, Antisense Research) Option Ex 695 .00 0
2013-01-15 Parshall B Lynne (COO, Secretary) Option Ex 1,715 .00 0
2013-01-15 Crooke Stanley T (Chairman, CEO and President) Option Ex 3,295 .00 0
2013-01-04 O'neil Patrick R. (SVP, Legal and General Counsel) Sale 1,296 10.76 13,944
2013-01-03 Monia Brett P (VP, Antisense Drug Discovery) Sale 311 10.84 3,371
2013-01-03 Geary Richard S (Sr VP, Development) Sale 265 10.84 2,872
2012-12-13 Geary Richard S (Sr VP, Development) Sale 6,000 9.62 57,750
2012-12-13 Geary Richard S (Sr VP, Development) Option Ex 6,000 5.25 31,500
2012-09-21 Crooke Stanley T (Chairman, CEO and President) Sale 29,462 14.06 414,235
2012-09-21 Crooke Stanley T (Chairman, CEO and President) Option Ex 29,462 6.84 201,520
2012-09-20 Crooke Stanley T (Chairman, CEO and President) Sale 30,000 15.01 450,240
2012-09-20 Crooke Stanley T (Chairman, CEO and President) Option Ex 30,000 6.04 181,350
2012-09-19 Crooke Stanley T (Chairman, CEO and President) Sale 30,000 14.81 444,450
2012-09-19 Crooke Stanley T (Chairman, CEO and President) Option Ex 30,000 5.25 157,500
2012-09-13 Crooke Stanley T (Chairman, CEO and President) Sale 27,074 14.55 393,926
2012-09-13 Crooke Stanley T (Chairman, CEO and President) Option Ex 27,074 5.25 142,138
2012-09-07 Parshall B Lynne (COO, Secretary) Sale 12,506 15.12 189,090
2012-09-07 Parshall B Lynne (COO, Secretary) Option Ex 12,506 6.84 85,541
2012-09-06 Monia Brett P (VP, Antisense Drug Discovery) Sale 12,031 15.25 183,472
2012-09-06 Monia Brett P (VP, Antisense Drug Discovery) Option Ex 12,031 5.25 63,162
2012-09-06 Reed John C (Director) Sale 4,900 15.18 74,357
2012-09-06 Reed John C (Director) Option Ex 4,900 5.17 25,333
2012-09-06 Parshall B Lynne (COO, Secretary) Sale 30,000 15.02 450,630
2012-09-06 Parshall B Lynne (COO, Secretary) Option Ex 30,000 5.93 177,930
2012-09-06 Crooke Stanley T (Chairman, CEO and President) Sale 30,000 15.02 450,540
2012-09-06 Crooke Stanley T (Chairman, CEO and President) Option Ex 30,000 5.51 165,450
2012-09-05 Parshall B Lynne (COO, Secretary) Sale 2,000 15.00 30,000
2012-09-05 Parshall B Lynne (COO, Secretary) Option Ex 2,000 5.25 10,500
2012-09-05 Crooke Stanley T (Chairman, CEO and President) Sale 15,000 14.82 222,345
2012-09-05 Crooke Stanley T (Chairman, CEO and President) Option Ex 15,000 5.25 78,750
2012-09-04 Reed John C (Director) Sale 5,100 15.17 77,367
2012-09-04 Reed John C (Director) Option Ex 5,100 5.17 26,367
2012-09-04 Parshall B Lynne (COO, Secretary) Sale 30,000 15.00 450,030
2012-09-04 Parshall B Lynne (COO, Secretary) Option Ex 30,000 5.25 157,500
2012-09-04 Crooke Stanley T (Chairman, CEO and President) Sale 30,000 14.11 423,240
2012-09-04 Crooke Stanley T (Chairman, CEO and President) Option Ex 30,000 5.25 157,500
2012-07-09 Geary Richard S (Sr VP, Development) Sale 5,686 13.47 76,590
2012-07-09 Geary Richard S (Sr VP, Development) Option Ex 5,686 5.25 29,851
2012-07-09 Reed John C (Director) Sale 10,000 13.99 139,900
2012-07-09 Reed John C (Director) Option Ex 10,000 3.95 39,500
2012-07-09 Bennett C Frank (SVP, Antisense Research) Sale 10,500 13.51 141,855
2012-07-09 Bennett C Frank (SVP, Antisense Research) Option Ex 10,500 6.83 71,662
2012-07-03 Monia Brett P (SVP, Antisense Drug Discovery) Sale 587 12.92 7,584
2012-07-03 Geary Richard S (Sr VP, Development) Sale 2,434 12.91 31,422
2012-07-03 Bennett C Frank (SVP, Antisense Research) Sale 6,000 12.91 77,460
2012-07-03 Bennett C Frank (SVP, Antisense Research) Option Ex 6,000 6.84 41,040
2012-06-25 Berthelsen Spencer R (Director) Sale 10,000 11.54 115,450
2012-06-25 Berthelsen Spencer R (Director) Option Ex 10,000 8.15 81,500
2012-06-22 Reed John C (Director) Sale 10,000 11.06 110,600
2012-06-22 Reed John C (Director) Option Ex 10,000 8.15 81,500
2012-06-14 Geary Richard S (Sr VP, Development) Sale 1,579 10.86 17,147
2012-06-12 Wender Joseph H (Director) Option Ex 10,000 8.15 81,500
2012-05-22 Berthelsen Spencer R (Director) Sale 17,269 9.56 165,091
2012-05-22 Berthelsen Spencer R (Director) Option Ex 17,269 9.40 162,328
2012-05-21 Berthelsen Spencer R (Director) Sale 2,731 9.42 25,726
2012-05-21 Berthelsen Spencer R (Director) Option Ex 2,731 9.40 25,671
2011-12-21 Geary Richard S (Senior Vice President) Sale 1,144 6.92 7,916
2011-12-21 Geary Richard S (Senior Vice President) Option Ex 1,144 5.80 6,635
2011-12-21 Bennett C Frank (Senior Vice President) Sale 1,555 6.92 10,760
2011-12-21 Bennett C Frank (Senior Vice President) Option Ex 1,555 5.80 9,019
2011-12-21 Parshall B Lynne (Director, COO) Sale 6,763 6.92 46,799
2011-12-21 Parshall B Lynne (Director, COO) Option Ex 6,763 5.80 39,225
2011-12-21 Crooke Stanley T (Chairman, President, CEO) Sale 17,800 6.92 123,176
2011-12-21 Crooke Stanley T (Chairman, President, CEO) Option Ex 17,800 5.80 103,240
2011-12-20 Geary Richard S (Senior Vice President) Sale 1,800 6.87 12,366
2011-12-20 Geary Richard S (Senior Vice President) Option Ex 1,800 5.80 10,440
2011-12-20 Bennett C Frank (Senior Vice President) Sale 2,500 6.87 17,175
2011-12-20 Bennett C Frank (Senior Vice President) Option Ex 2,500 5.80 14,500
2011-12-20 Parshall B Lynne (Director, COO) Sale 10,600 6.87 72,822
2011-12-20 Parshall B Lynne (Director, COO) Option Ex 10,600 5.80 61,480
2011-12-20 Crooke Stanley T (Chairman, President, CEO) Sale 28,700 6.87 197,169
2011-12-20 Crooke Stanley T (Chairman, President, CEO) Option Ex 28,700 5.80 166,460
2011-12-19 Geary Richard S (Senior Vice President) Sale 1,100 6.86 7,546
2011-12-19 Geary Richard S (Senior Vice President) Option Ex 1,100 5.80 6,380
2011-12-19 Bennett C Frank (Senior Vice President) Sale 1,500 6.86 10,290
2011-12-19 Bennett C Frank (Senior Vice President) Option Ex 1,500 5.80 8,700
2011-12-19 Parshall B Lynne (Director, COO) Sale 6,900 6.86 47,334
2011-12-19 Parshall B Lynne (Director, COO) Option Ex 8,900 87.83 781,678
2011-12-19 Crooke Stanley T (Chairman, President, CEO) Sale 18,100 6.86 124,166
2011-12-19 Crooke Stanley T (Chairman, President, CEO) Option Ex 18,100 5.80 104,980
2011-12-16 Geary Richard S (Senior Vice President) Sale 1,000 6.79 6,790
2011-12-16 Geary Richard S (Senior Vice President) Option Ex 1,000 5.80 5,800
2011-12-16 Bennett C Frank (Senior Vice President) Sale 1,500 6.79 10,185
2011-12-16 Bennett C Frank (Senior Vice President) Option Ex 1,500 5.80 8,700
2011-12-16 Parshall B Lynne (Director, COO) Sale 6,000 6.79 40,740
2011-12-16 Parshall B Lynne (Director, COO) Option Ex 4,000 5.80 23,200
2011-12-16 Crooke Stanley T (Chairman, President, CEO) Sale 16,500 6.79 112,035
2011-12-16 Crooke Stanley T (Chairman, President, CEO) Option Ex 16,500 5.80 95,700
2011-08-04 Bennett C Frank (Senior Vice President) Sale 10,000 7.62 76,210
2011-08-04 Bennett C Frank (Senior Vice President) Option Ex 10,000 5.25 52,500
2011-07-28 Bennett C Frank (Senior Vice President) Sale 1,000 8.60 8,600
2010-12-29 Geary Richard S (Senior Vice President) Sale 1,980 10.31 20,423
2010-12-29 Geary Richard S (Senior Vice President) Option Ex 1,980 9.62 19,057
2010-12-29 Bennett C Frank (Senior Vice President) Sale 4,600 10.31 47,449
2010-12-29 Bennett C Frank (Senior Vice President) Option Ex 4,600 9.62 44,275
2010-12-29 Parshall B Lynne (Director, COO) Sale 6,400 10.31 66,016
2010-12-29 Parshall B Lynne (Director, COO) Option Ex 6,400 9.62 61,600
2010-12-29 Crooke Stanley T (Chairman, President, CEO) Sale 12,000 10.31 123,780
2010-12-29 Crooke Stanley T (Chairman, President, CEO) Option Ex 12,000 9.62 115,500
2010-12-27 Geary Richard S (Senior Vice President) Sale 3,300 10.42 34,386
2010-12-27 Geary Richard S (Senior Vice President) Option Ex 3,300 9.62 31,762
2010-12-27 Bennett C Frank (Senior Vice President) Sale 7,700 10.42 80,234
2010-12-27 Bennett C Frank (Senior Vice President) Option Ex 7,700 9.62 74,112
2010-12-27 Parshall B Lynne (Director, COO) Sale 10,800 10.42 112,536
2010-12-27 Parshall B Lynne (Director, COO) Option Ex 10,800 9.62 103,950
2010-12-27 Crooke Stanley T (Chairman, President, CEO) Sale 20,000 10.42 208,400
2010-12-27 Crooke Stanley T (Chairman, President, CEO) Option Ex 20,000 9.62 192,500
2010-12-23 Geary Richard S (Senior Vice President) Sale 600 10.53 6,315
2010-12-23 Geary Richard S (Senior Vice President) Option Ex 600 9.62 5,775
2010-12-23 Bennett C Frank (Senior Vice President) Sale 1,500 10.53 15,787
2010-12-23 Bennett C Frank (Senior Vice President) Option Ex 1,500 9.62 14,437
2010-12-23 Parshall B Lynne (COO) Sale 2,100 10.53 22,102
2010-12-23 Parshall B Lynne (COO) Option Ex 2,100 9.62 20,212
2010-12-23 Crooke Stanley T (Chairman, President, CEO) Sale 4,000 10.53 42,100
2010-12-23 Crooke Stanley T (Chairman, President, CEO) Option Ex 4,000 9.62 38,500
2010-12-22 Geary Richard S (Senior Vice President) Sale 2,600 10.52 27,352
2010-12-22 Geary Richard S (Senior Vice President) Option Ex 2,600 9.62 25,025
2010-12-22 Bennett C Frank (Senior Vice President) Sale 6,200 10.52 65,224
2010-12-22 Bennett C Frank (Senior Vice President) Option Ex 6,200 9.62 59,675
2010-12-22 Parshall B Lynne (COO) Sale 4,350 10.52 45,762
2010-12-22 Parshall B Lynne (COO) Option Ex 13,050 9.92 129,495
2010-12-22 Crooke Stanley T (Chairman, President, CEO) Sale 16,000 10.52 168,320
2010-12-22 Crooke Stanley T (Chairman, President, CEO) Option Ex 16,000 9.62 154,000
2010-07-23 Bennett C Frank (Senior Vice President) Sale 1,100 9.60 10,560
2010-06-30 Bennett C Frank (Senior Vice President) Sale 1,000 9.75 9,750
2010-06-30 Bennett C Frank (Senior Vice President) Option Ex 1,000 5.80 5,800
2010-06-29 Bennett C Frank (Senior Vice President) Sale 3,000 9.71 29,138
2010-06-29 Bennett C Frank (Senior Vice President) Option Ex 3,000 5.80 17,400
2010-06-28 Bennett C Frank (Senior Vice President) Sale 6,000 10.01 60,060
2010-06-28 Bennett C Frank (Senior Vice President) Option Ex 6,000 5.80 34,800
2009-12-31 Parshall B Lynne (Director, COO) Sale 7,090 11.21 79,478
2009-12-31 Parshall B Lynne (Director, COO) Option Ex 7,090 6.81 48,304

Insider trading activities including stock purchases, stock sales, and option exercises of IONS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ionis Pharmaceuticals Inc (symbol IONS, CIK number 874015) see the Securities and Exchange Commission (SEC) website.